These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

485 related items for PubMed ID: 18579664

  • 1. Intratumoral estrogens and estrogen receptors in human non-small cell lung carcinoma.
    Niikawa H, Suzuki T, Miki Y, Suzuki S, Nagasaki S, Akahira J, Honma S, Evans DB, Hayashi S, Kondo T, Sasano H.
    Clin Cancer Res; 2008 Jul 15; 14(14):4417-26. PubMed ID: 18579664
    [Abstract] [Full Text] [Related]

  • 2. Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen.
    Stabile LP, Davis AL, Gubish CT, Hopkins TM, Luketich JD, Christie N, Finkelstein S, Siegfried JM.
    Cancer Res; 2002 Apr 01; 62(7):2141-50. PubMed ID: 11929836
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Estrogen receptors in atherosclerotic human aorta: inhibition of human vascular smooth muscle cell proliferation by estrogens.
    Nakamura Y, Suzuki T, Miki Y, Tazawa C, Senzaki K, Moriya T, Saito H, Ishibashi T, Takahashi S, Yamada S, Sasano H.
    Mol Cell Endocrinol; 2004 Apr 30; 219(1-2):17-26. PubMed ID: 15149723
    [Abstract] [Full Text] [Related]

  • 6. Steroid sulfatase and estrogen sulfotransferase in colon carcinoma: regulators of intratumoral estrogen concentrations and potent prognostic factors.
    Sato R, Suzuki T, Katayose Y, Miura K, Shiiba K, Tateno H, Miki Y, Akahira J, Kamogawa Y, Nagasaki S, Yamamoto K, Ii T, Egawa S, Evans DB, Unno M, Sasano H.
    Cancer Res; 2009 Feb 01; 69(3):914-22. PubMed ID: 19141651
    [Abstract] [Full Text] [Related]

  • 7. Intratumoral localization of aromatase and interaction between stromal and parenchymal cells in the non-small cell lung carcinoma microenvironment.
    Miki Y, Suzuki T, Abe K, Suzuki S, Niikawa H, Iida S, Hata S, Akahira J, Mori K, Evans DB, Kondo T, Yamada-Okabe H, Sasano H.
    Cancer Res; 2010 Aug 15; 70(16):6659-69. PubMed ID: 20710045
    [Abstract] [Full Text] [Related]

  • 8. Intratumoral concentration of sex steroids and expression of sex steroid-producing enzymes in ductal carcinoma in situ of human breast.
    Shibuya R, Suzuki T, Miki Y, Yoshida K, Moriya T, Ono K, Akahira J, Ishida T, Hirakawa H, Evans DB, Sasano H.
    Endocr Relat Cancer; 2008 Mar 15; 15(1):113-24. PubMed ID: 18310280
    [Abstract] [Full Text] [Related]

  • 9. Oestrogen receptor beta over expression in males with non-small cell lung cancer is associated with better survival.
    Skov BG, Fischer BM, Pappot H.
    Lung Cancer; 2008 Jan 15; 59(1):88-94. PubMed ID: 17905466
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Aromatase inhibitors in human lung cancer therapy.
    Weinberg OK, Marquez-Garban DC, Fishbein MC, Goodglick L, Garban HJ, Dubinett SM, Pietras RJ.
    Cancer Res; 2005 Dec 15; 65(24):11287-91. PubMed ID: 16357134
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Highly concordant coexpression of aromatase and estrogen receptor beta in non-small cell lung cancer.
    Abe K, Miki Y, Ono K, Mori M, Kakinuma H, Kou Y, Kudo N, Koguchi M, Niikawa H, Suzuki S, Evans DB, Sugawara S, Suzuki T, Sasano H.
    Hum Pathol; 2010 Feb 15; 41(2):190-8. PubMed ID: 19800101
    [Abstract] [Full Text] [Related]

  • 14. Progesterone receptor in non-small cell lung cancer--a potent prognostic factor and possible target for endocrine therapy.
    Ishibashi H, Suzuki T, Suzuki S, Niikawa H, Lu L, Miki Y, Moriya T, Hayashi S, Handa M, Kondo T, Sasano H.
    Cancer Res; 2005 Jul 15; 65(14):6450-8. PubMed ID: 16024650
    [Abstract] [Full Text] [Related]

  • 15. Co-expression of estrogen receptor beta and aromatase in Japanese lung cancer patients: gender-dependent clinical outcome.
    Verma MK, Miki Y, Abe K, Nagasaki S, Niikawa H, Suzuki S, Kondo T, Sasano H.
    Life Sci; 2012 Oct 22; 91(15-16):800-8. PubMed ID: 22982181
    [Abstract] [Full Text] [Related]

  • 16. Cytoplasmic estrogen receptor β as a potential marker in human non-small cell lung carcinoma.
    Verma MK, Miki Y, Abe K, Niikawa H, Sasano H.
    Expert Opin Ther Targets; 2012 Mar 22; 16 Suppl 1():S91-102. PubMed ID: 22313325
    [Abstract] [Full Text] [Related]

  • 17. Aromatase in human lung carcinoma.
    Verma MK, Miki Y, Sasano H.
    Steroids; 2011 Jul 22; 76(8):759-64. PubMed ID: 21392519
    [Abstract] [Full Text] [Related]

  • 18. Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women.
    Schwartz AG, Wenzlaff AS, Prysak GM, Murphy V, Cote ML, Brooks SC, Skafar DF, Lonardo F.
    J Clin Oncol; 2007 Dec 20; 25(36):5785-92. PubMed ID: 18089876
    [Abstract] [Full Text] [Related]

  • 19. Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines.
    Smuc T, Rizner TL.
    Chem Biol Interact; 2009 Mar 16; 178(1-3):228-33. PubMed ID: 19022235
    [Abstract] [Full Text] [Related]

  • 20. Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway.
    Sauvé K, Lepage J, Sanchez M, Heveker N, Tremblay A.
    Cancer Res; 2009 Jul 15; 69(14):5793-800. PubMed ID: 19584281
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.